texaline

structure in first source

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Canivet, Jérôme: 1 article (08/2011)
2.	Itami, Kenichiro: 1 article (08/2011)
3.	Komiyama, Masato: 1 article (08/2011)
4.	Muto, Kei: 1 article (08/2011)
5.	Yamaguchi, Junichiro: 1 article (08/2011)
6.	Yamamoto, Takuya: 1 article (08/2011)

1.	Hyperuricemia 08/29/2011 - "This newly developed methodology has been successfully applied to the syntheses of febuxostat (a xanthine oxidase inhibitor that is effective for the treatment of gout and hyperuricemia), tafamidis (effective for the treatment of TTR amyloid polyneuropathy), and texaline (a natural product having antitubercular activity)."
2.	Amyloid Neuropathies (Amyloid Neuropathy) 08/29/2011 - "This newly developed methodology has been successfully applied to the syntheses of febuxostat (a xanthine oxidase inhibitor that is effective for the treatment of gout and hyperuricemia), tafamidis (effective for the treatment of TTR amyloid polyneuropathy), and texaline (a natural product having antitubercular activity)."
3.	Gout 08/29/2011 - "This newly developed methodology has been successfully applied to the syntheses of febuxostat (a xanthine oxidase inhibitor that is effective for the treatment of gout and hyperuricemia), tafamidis (effective for the treatment of TTR amyloid polyneuropathy), and texaline (a natural product having antitubercular activity)."